Concepedia
Statistics
Publications
9
Citations
801
H-Index
Active since
2002
Affiliations
AstraZeneca (United States)(Current)
Oregon Health & Science University
University at Buffalo, State University of New York
Wenxian Wang is an author at AstraZeneca (United States) specializing in medicine, cell biology, and cell signaling.
Top concepts
MedicineCell BiologyOncologyCytoskeletonPharmacologyTumor BiologyCancer BiologyCell SignalingDrug DiscoveryCancer Research
Publications per year
2002–2022
Placental overgrowth in mice lacking the imprinted gene <i>Ipl</i>
Dale Frank, Weiwei Fortino, Lorraine N. Clark et al. · Proceedings of the National Academy of Sciences · 2002 · 216 citations · Full text
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 147 citations · Full text
Azd5153 Exposure, Pathology, Pharmacotherapy +17
Potent and selective bivalent inhibitors of BET bromodomains
Michael J. Waring, Huawei Chen, Alfred A. Rabow et al. · Nature Chemical Biology · 2016 · 134 citations · Full text
Medicinal Chemistry, Selective Bivalent Inhibitors, Medicine +3
Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1
Jiaquan Wu, Keith Mikule, Wenxian Wang et al. · ACS Chemical Biology · 2013 · 120 citations
Molecular Biology, Small Molecule Inhibitor, Cytoskeleton +21
Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation as a Strategy against Cancer
Chang-Rung Chen, Wenxian Wang, Harry A. Rogoff et al. · Cancer Research · 2005 · 49 citations
Chemoprevention Strategy, Apoptosis, Cell Death +16
1–5 of 9